Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease - Wikidata - awgldk - TriplyDB

Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease

Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease

http://www.wikidata.org/entity/Q35210184

about

Role of vitamin D in diabetes mellitus and chronic kidney disease Vascular calcification, bone and mineral metabolism after kidney transplantation Klotho, stem cells, and aging Fibroblast growth factor 23 Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway FGF-23, Klotho and Vitamin D Levels in Scleroderma Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.The effect of renin angiotensin system genetic variants in acute pancreatitis.A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 diabetes.Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study Active vitamin D treatment for reduction of residual proteinuria: a systematic review.Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial Vitamin D receptor, an important transcription factor associated with aldosterone-producing adenoma.Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease.Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis.Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.The emerging role of Klotho in clinical nephrology.Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.FGF23 production by osteocytes.Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy.Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infa Poststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention.Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock Multiple faces of fibroblast growth factor-23 Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.

P2860

Q26765231-F835B51C-2076-4878-BDED-D271680D54A8 Q26771400-2BC6615B-3656-4515-A920-04A98359E193 Q26783185-4E18EE12-A397-42BE-B483-B51F3CC0FA25 Q26829294-65C76430-117E-4009-8932-3255628D9DD8 Q27026805-1B59FAB9-0BE2-4B2E-AE15-DD47FB62FC3E Q33711101-F66C8890-D2A3-42F4-A847-B8DB34C5E2FE Q34244300-650B8C41-3630-4D3C-8F13-013CF467D963 Q34353579-5BDB68B0-594E-40B5-B2C8-533FF761407E Q34412241-23048A35-2191-4C30-B3E1-4AE881F83899 Q34421217-35DD135A-F0F6-4D20-ABD4-A30D2728CAFF Q34506761-C1DDAA71-7823-4162-9244-67E6D89203FF Q34588377-03384455-0DFF-48DD-A946-41AB17166523 Q34912750-49E36C1E-852B-4A3D-B5C9-36DA575DC89E Q34941418-C1EA03C8-B0E6-460A-A35A-D0980646D0C1 Q34962806-1E7DDD7A-9C3C-403E-9E57-BFA24A608C41 Q35008805-7CFAD470-6995-4700-9415-E98C921D8CA9 Q35077564-3C900A23-E9FC-4A05-BAB8-AE6D560F2EA5 Q35153209-DDA43D89-9ED2-4964-9AE6-91AC8F91EE4E Q35232118-EEC3E709-A07B-4D34-8245-80EC96261E39 Q35997370-1066F3AB-7C80-4579-A88F-4B05C663639C Q36001789-28C99420-68E8-450E-A39E-270FB9F1524B Q36015686-3B0FF93A-BB1D-455B-A068-330217AD0CB5 Q36074718-054635EA-69E8-41C7-AC89-C90BC4D59345 Q36098355-09423E4F-DCC5-470F-A441-7F3DF39AF6C2 Q36349451-3C894BA7-5639-40AB-9B15-FDCEC285296D Q36580372-1528923A-F0C5-4BE1-9EC9-DDE3755C70C5 Q36639867-D3783719-2E5F-4F8D-B700-1433ABA689B1 Q36648170-035E4274-45DD-4D53-A510-1D7F1E77F2A9 Q36801566-A009C011-E80A-4764-BA3E-72B7F27FC602 Q37152752-84871D97-B14D-439A-BA92-F554F048F761 Q37162723-A3828D95-C2B8-4E89-AB05-A580486A3C30 Q37177523-A2EC411E-3972-4917-A4EF-3AFE65AD7EF7 Q37239835-BF6372BD-FF1A-49E7-B694-28CB52517DA7 Q37280819-B21CE6FB-073B-4544-86AD-84B0EC1871B2 Q37280832-19FF442B-9466-4FDE-9917-098E81E8868C Q37291894-996358B0-C7E3-4470-BC79-5CBD8188C8C7 Q37312020-C802EF72-9F2F-4A95-AFF3-68C5DD2FA2CD Q37342971-1A6FDAB8-5200-4A3E-B43C-E65E4563A86F Q37432867-46361FD1-BC4D-4C6D-899C-6FD4FD90E027 Q37690771-5EB87F56-2615-4618-90C4-59409082EDDE

P2860

Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease

http://www.wikidata.org/entity/Q35210184

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cross talk between the renin-a ...... otho in chronic kidney disease

@ast

Cross talk between the renin-a ...... otho in chronic kidney disease

@en

type

label

Cross talk between the renin-a ...... otho in chronic kidney disease

@ast

Cross talk between the renin-a ...... otho in chronic kidney disease

@en

prefLabel

Cross talk between the renin-a ...... otho in chronic kidney disease

@ast

Cross talk between the renin-a ...... otho in chronic kidney disease

@en

P1433

Q35210184-257A62C9-A47D-49CC-9B15-7B15C8C04486

P1476

Q35210184-52066D33-0948-471D-B7AE-989A2B456988

P2093

Q35210184-0A22F1B9-D056-452E-BDB6-AFD11D916E92

Q35210184-30073768-8BB0-4DE8-BA69-73A27D69E677

Q35210184-42540516-F409-4A8B-86D8-A3F4FC8C7BBD

Q35210184-D50B8ED0-2EC2-4DA5-B1E0-7FFEAA167B68

P2860

Q35210184-02FF6540-81E0-48ED-BF69-2AE6610092C5

Q35210184-06ED9109-EC90-4E37-B7F4-CD06CD251509

Q35210184-0DD652AA-0E81-4A8D-868D-759C555F4003

Q35210184-14B56B37-47DC-48E1-ADEE-BE0D0490783C

Q35210184-1865F5E1-F34E-4D64-B076-25CD4DF2B6EB

Q35210184-19D0B336-95E3-4C87-877D-323EF68C24C2

Q35210184-1B0097E3-60F4-4FD9-B180-11A3B1857937

Q35210184-1B7AAC5E-A85D-44C0-83E9-C78BC1DC01E5

Q35210184-1C1A5D17-916D-4340-A968-D9C2AF7A7182

Q35210184-22DA502E-8FF8-4657-BE99-49F5A45397B2

P304

Q35210184-E4DCA7E4-F6BB-49F6-8714-3C6E22B77AB3

P31

Q35210184-41282EFA-1C5A-47DC-A28C-34747CF3A82E

P356

Q35210184-A1E753EF-596E-491B-B01D-9FF67F614341

P433

Q35210184-54598B4B-4DD8-4962-97CE-41CA47E91E82

P478

Q35210184-DC504D7F-AB26-4EA4-A7B2-D3C3408AC47A

P577

Q35210184-A93A5AC9-02CE-4ACF-85FB-21083A9F9F8F

P698

Q35210184-141A8864-EB5F-4562-AE0C-D4BEF492AC9A

P921

Q35210184-03AA10DF-6E97-408D-BA7C-0F50D99AB5E6

P932

Q35210184-EEC80E00-6D2B-4AAC-AA5A-B4DD96D53D01

P356

P1433

Journal of the American Society of Nephrology

P1476

Cross talk between the renin-a ...... otho in chronic kidney disease

@en

P2093

Gerjan Navis

http://www.w3.org/2001/XMLSchema#string

Marc G Vervloet

http://www.w3.org/2001/XMLSchema#string

Martin H de Borst

http://www.w3.org/2001/XMLSchema#string

Piet M ter Wee

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis

Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy

Klotho converts canonical FGF receptor into a specific receptor for FGF23

In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage

Regulation of fibroblast growth factor-23 signaling by klotho

P304

1603-1609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010121251

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21852584

http://www.w3.org/2001/XMLSchema#string

P921

P932

3171931

http://www.w3.org/2001/XMLSchema#string